new glp 1 retatrutide 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of 🎙️ NEW EPISODE: Retatrutide—The Triple

If your blood sugar levels need more management (or if the goal is further weight loss), the dose can be increased further

No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance

The results: In global studies like SURMOUNT-1 (2022) , people lost up to 2022% of their body weight, one of the highest reductions ever seen in obesity research

They may take you back down to a lower dose , at least temporarily , to see if that works better for you

Tirzepatide (Mounjaro)

5 Intermittent fasting Intermittent fasting (IF) promotes weight loss by reducing caloric intake and inducing metabolic switching, during which the body transitions from glucose utilization to fat oxidation as its primary source of energy